Mass spectrometry (MS)-based proteomics have been increasingly implemented in various
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …

Cancer remains one of the most complex and challenging diseases in mankind. To address
the need for a personalized treatment approach for particularly complex tumor cases …

Urinary extracellular vesicles (EVs) are an attractive source of bladder cancer biomarkers.
Here, a protein biomarker discovery study was performed on the protein content of small …

In the last decades, the development of high‐throughput molecular assays has
revolutionised cancer diagnostics, paving the way for the concept of personalised cancer …

Mass spectrometry-based proteomics has been extensively applied to current biomedical
research. From such large-scale identification of proteins, several computational tools have …

Lung cancer is one of the common malignant cancers worldwide. Immune checkpoint
inhibitor (ICI) therapy has improved survival of lung cancer patients. However, ICI therapy …

Central nervous system (CNS) tumors are the leading cause of cancer death in pediatric
patients. Though these tumors typically require invasive surgical procedures to diagnose …

Background Oncogenic transformation alters intracellular metabolism and contributes to the
growth of malignant cells. Metabolomics, or the study of small molecules, can reveal insight …

Parathyroid carcinoma is a rare disease that needs an additional diagnostic tool and wide
therapeutic options. The genomics and proteomics approach may help to find the tools to …

Liquid chromatography-tandem mass spectrometry (LC–MS/MS) is a widely employed
technique in proteomics research for studying the proteome biology of various clinical …